Cardiovascular mortality · adults with or without existing CVD
High probably leads to lower cardiovascular mortality – cardiovascular deaths compared with low long‐chain omega‐3 fats (moderate certainty).
1 finding from 1 review
Measures of adiposity – LCn3 – Weight, kg · adults with or without existing CVD
1 finding from 1 review
Body‐mass index (BMI) · adults with or without existing CVD
2 findings from 1 review
Serum total cholesterol – LCn3 – TC, mmol/L · adults with or without existing CVD
1 finding from 1 review
Serum fasting triglyceride (TG, mmol/L) · adults with or without existing CVD
1 finding from 1 review
Serum low‐density lipoprotein (LDL, mmol/L) · adults with or without existing CVD
2 findings from 1 review
Measures of adiposity – ALA – Weight, kg · adults with or without existing CVD
1 finding from 1 review
Serum total cholesterol – ALA – TC, mmol/L · adults with or without existing CVD
1 finding from 1 review
Serum triglyceride, ALA ‐ fasting TG, mmol/L · adults with or without existing CVD
1 finding from 1 review
Cardiovascular events · adults with or without existing CVD
High showed no clear difference in cardiovascular events compared with low long‐chain omega‐3 fats (high certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
High may leads to lower coronary heart disease events – CHD events compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
Stroke · adults with or without existing CVD
High showed no clear difference in stroke compared with low long‐chain omega‐3 fats (moderate certainty).
1 finding from 1 review
Arrhythmias · adults with or without existing CVD
High showed no clear difference in arrhythmias compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
Harms: bleeding · adults with or without existing CVD
It is very uncertain whether high changes harms: bleeding compared with low long‐chain omega‐3 fats (very low certainty).
1 finding from 1 review
Harms: pulmonary embolus or DVT · adults with or without existing CVD
It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low long‐chain omega‐3 fats (very low certainty).
1 finding from 1 review
HDL‐cholesterol · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
All‐cause mortality Study duration range 12‐96 months Omega‐6 dose range 1.5%‐24.5% E · adults with or without existing CVD
Higher showed no clear difference in all‐cause mortality Study duration range 12‐96 months Omega‐6 dose… compared with lower omega‐6: primary outcomes (low certainty).
1 finding from 1 review
LDL Study duration range 12‐24 months Omega‐6 dose range 2.0%‐15.0% E · adults with or without existing CVD
1 finding from 1 review
HDL Study duration range 12‐24 months Omega‐6 dose range 2.0%‐15.0% E · adults with or without existing CVD
1 finding from 1 review